A randomised, controlled trial of the effects of a mobile telehealth intervention on clinical and patient-reported outcomes in people with poorly controlled diabetes.

Source: Baron, J. S., et al. 2017 - Pubmed ID: 26880694

Setting: UK, Diabetes clinic

Study design:



Follow up: 9 months

Patient group:

Sample size:

Total: 81(71)

IG: 45 (40)

CG: 36 (31)


Inclusion criteria:

  • Diabetes type 1 or 2
  • Hba1c>7.5%
Type of technology:

Home monitoring (Mobile telehealth (MTH))

  • Storing and transmitting data
  • Colour-coded graphical feedback

Phone consultation

  • Clinical data review
  • Education

Intervention:  Data on BP and BG recorded and stored by patients. Nurse accessed data via web and provided feedback on the clinical readings (as needed) and education on lifestyle changes (six weekly calls). The nurse supported insulin titration. An engineer delivered devices/equipment and training.


Duration: NA

Add on: +


Control group: Usual care (Follow-up appointments with nurse every 3-4. months, 1-2 annual appointments with diabetes consultants)

Clinical effect/ Patient safety:

Clinical effect:

  • HbAIc  →
  • Systolic Bp →
  • Diastolic Bp→
  • Daily insulin  dose →
  • SF12v2 physical →
  • SF12c2 Mental →
  • DHP-18-Barriers to activity →
  • DHP-18-Disinhibited eating →
  • DHP-18-psychological distress →
  • CESD-10 →
  • STAI-6 →

Patient safety: NA

Patient experiences/ Staff experiences:

Patient experiences: NA


Staff experiences: NA

Costs and organization:



  • BG meter
  • BP monitor
  • Bluetooth cradle

Staff resources

  • Education/training


Staff resources

  • Telephone call
  • Data monitoring
  • Technical assistance

Organization: NA

Health care utilization:

  • Diabetes outpatient appointments →
Scroll to Top


“↑”: Statistically significant increase

“↓”: Statistically significant decrease

“→”: Statistically insignificant (no difference)